Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sarin

Showing results (201-210 of 228) with videos related to

Pageof 23
Sort By:
Vaccine|March 17, 1999
Booster immunization of HIV-1 negative volunteers with HGP-30 vaccine induces protection against HIV-1 virus challenge in SCID miceP S Sarin, J E Talmadge, P Heseltine, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 1, 1995
HIV-1 p17 synthetic peptide vaccine HGP-30: induction of immune response in human subjects and preliminary evidence of protection against HIV challenge in SCID miceP S Sarin, C A Mora, P H Naylor, et al.
Antiviral Research|April 1, 1989
Inhibition of HIV replication by liposomal encapsulated amphotericin BD R Pontani, D Sun, J W Brown, et al.
AIDS Research and Human Retroviruses|January 1, 1987
Genomic diversity of Zairian HIV isolates: biological characteristics and clinical manifestation of HIV infectionF Laure, R Leonard, K Mbayo, et al.
International Journal of Immunopharmacology|November 25, 2000
Flt3 ligand enhances the immunogenicity of a gag-based HIV-1 vaccineV M Pisarev, P Parajuli, R L Mosley, et al.
The Journal of Infectious Diseases|March 1, 1983
Epidemiology of human T-cell leukemia/lymphoma virusW A Blattner, D W Blayney, M Robert-Guroff, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1992
Cell-mediated immunity against HGP-30, a group-specific peptide of HIV p17 in individuals infected with the AIDS virusA Willer, A Achour, J P Mbika, et al.
Antiviral Research|April 1, 1988
Dual biological activity of apurinic acid on human lymphocytes: induction of interferon-gamma and protection from human immunodeficiency virus infection in vitroW E Müller, P S Sarin, D Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1987
Human immunodeficiency virus contains an epitope immunoreactive with thymosin alpha 1 and the 30-amino acid synthetic p17 group-specific antigen peptide HGP-30P H Naylor, C W Naylor, M Badamchian, et al.
Lancet (London, England)|September 7, 1985
ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy AfricansR J Biggar, P L Gigase, M Melbye, et al.
Pageof 23

Showing results (201-210 of 228) with videos related to

Sort By:
Pageof 23
Vaccine|March 17, 1999
Booster immunization of HIV-1 negative volunteers with HGP-30 vaccine induces protection against HIV-1 virus challenge in SCID miceP S Sarin, J E Talmadge, P Heseltine, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 1, 1995
HIV-1 p17 synthetic peptide vaccine HGP-30: induction of immune response in human subjects and preliminary evidence of protection against HIV challenge in SCID miceP S Sarin, C A Mora, P H Naylor, et al.
Antiviral Research|April 1, 1989
Inhibition of HIV replication by liposomal encapsulated amphotericin BD R Pontani, D Sun, J W Brown, et al.
AIDS Research and Human Retroviruses|January 1, 1987
Genomic diversity of Zairian HIV isolates: biological characteristics and clinical manifestation of HIV infectionF Laure, R Leonard, K Mbayo, et al.
International Journal of Immunopharmacology|November 25, 2000
Flt3 ligand enhances the immunogenicity of a gag-based HIV-1 vaccineV M Pisarev, P Parajuli, R L Mosley, et al.
The Journal of Infectious Diseases|March 1, 1983
Epidemiology of human T-cell leukemia/lymphoma virusW A Blattner, D W Blayney, M Robert-Guroff, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1992
Cell-mediated immunity against HGP-30, a group-specific peptide of HIV p17 in individuals infected with the AIDS virusA Willer, A Achour, J P Mbika, et al.
Antiviral Research|April 1, 1988
Dual biological activity of apurinic acid on human lymphocytes: induction of interferon-gamma and protection from human immunodeficiency virus infection in vitroW E Müller, P S Sarin, D Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1987
Human immunodeficiency virus contains an epitope immunoreactive with thymosin alpha 1 and the 30-amino acid synthetic p17 group-specific antigen peptide HGP-30P H Naylor, C W Naylor, M Badamchian, et al.
Lancet (London, England)|September 7, 1985
ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy AfricansR J Biggar, P L Gigase, M Melbye, et al.
Pageof 23